First Wave BioPharma, Inc. carries a market capitalization of 5.99M, placing it among publicly traded companies globally.
| Market Cap | 5.99M |
| Enterprise Value | N/A |
First Wave BioPharma, Inc.'s stock has declined approximately -92.21053% over the past 52 weeks. The 50-day moving average sits at 3.25, while the 200-day moving average is 5.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -92.21053% |
| 50-Day Moving Average | 3.25 |
| 200-Day Moving Average | 5.14 |
| Average Volume (20 Days) | N/A |
First Wave BioPharma, Inc.'s most recent stock split took place on December 18, 2023 with a 20:1 split ratio.
| Last Split Date | 12/18/2023 |
| Split Ratio | 20:1 |